Latest Safety News

Nyrada’s experimental drug NYR-BI03 shows promising cardioprotective and anti-arrhythmic effects in animal models, reinforcing its potential as a treatment for acute myocardial infarction.

Transurban Group is streamlining operations with a workforce reduction of around 300 roles, targeting over $50 million in annual cost savings while maintaining its FY25 distribution guidance.

Transurban Group is streamlining operations with a workforce reduction of approximately 300 employees, aiming to save over $50 million annually while maintaining its FY25 distribution guidance.

Orica Limited reported its strongest half-year EBIT in over a decade, driven by robust demand for premium blasting products and technology adoption, alongside significant safety and sustainability achievements.

Orica Limited reported a robust first half FY2025 with a 40% rise in NPAT pre-significant items and strong cash flow, underpinned by demand for premium blasting and digital solutions. The company also announced a $400 million share buy-back and a 32% higher interim dividend.

Spectur Limited appoints Anthony Schmidt as CEO, accelerating its transition to a scalable SaaS model and targeting operational cashflow neutrality by mid-2025 amid a $3 billion addressable market.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Novo Resources reported a reduced net loss of CAD 1.625 million in Q1 2025, progressing exploration with a new aircore drilling program in Western Australia while facing liquidity challenges that cast doubt on its near-term financial sustainability.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

Larvotto Resources has released a definitive feasibility study for its Hillgrove Antimony-Gold Project, confirming robust economics and a targeted production start in 2026. The study outlines an 8-year mine life with strong margins and advanced project financing talks.

HyTerra Limited has confirmed hydrogen concentrations up to 96.1% in its Sue Duroche 3 well in Kansas, reinforcing the potential of its natural hydrogen exploration program. Elevated helium levels were also detected, with further testing planned to assess commercial viability.

Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.